Anticoagulation Medical Home

NACompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

November 3, 2017

Study Completion Date

January 5, 2018

Conditions
Venous ThromboembolismPatient-Centered Care
Interventions
BEHAVIORAL

Enhanced Assessment and Education

Patients in the Intervention Group will: 1) have an in-home pharmacist medication assessment; 2) receive enhanced medication instructions (including pictograms); 3) receive an additional individualized assessment and educational session with a clinician provider related to the medication management for their disease (VTE).

Trial Locations (1)

01566

UMass Medical School, Worcester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER

NCT02870296 - Anticoagulation Medical Home | Biotech Hunter | Biotech Hunter